Wilmington, DE, United States of America

Yong Ni

This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Incyte Corporation, Incyte Holdings Corporation, Incyte Holdings Comoration. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Ni. Retrieved from https://idiyas.com/inventor/yong-ni-pw97x1ji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Yong Ni

Introduction

Yong Ni, an accomplished inventor based in Wilmington, DE, has made significant strides in the pharmaceutical field, notably in the development of sustained-release dosage forms. With a total of six patents to his name, his work is pivotal in treating various Janus kinase-associated diseases.

Latest Patents

Yong Ni’s recent patent focuses on the creation of sustained-release formulations and dosage forms of ruxolitinib. This invention is particularly valuable for treating myeloproliferative disorders and related conditions, as it provides a more effective means of administering medication over time.

Career Highlights

Throughout his career, Yong Ni has been associated with prominent companies, including Incyte Corporation and Incyte Holdings Corporation. His work at these institutions has allowed him to collaborate on groundbreaking research and contribute to vital advancements in pharmaceuticals.

Collaborations

In his professional journey, Yong has worked alongside notable colleagues such as Bhavnish Parikh and Krishnaswamy Yeleswaram. Their collaborations have resulted in innovative approaches to drug formulation, further enhancing the therapeutic options available for patients.

Conclusion

Yong Ni’s contributions to the field of pharmaceuticals through his inventive patents highlight the importance of innovation in addressing complex medical challenges. As he continues to develop new formulations, his work will undoubtedly influence the future of treatment for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…